Breast cancer-derived exosomal miR-105-5p facilitates the transformation of NFs into CAFs through LATS2-NF-κB signaling

  • 0Department of Pathology, Shandong Second Medical University, Weifang 261053, China.

|

|

Summary

This summary is machine-generated.

Breast cancer exosomes transform normal fibroblasts into cancer-associated fibroblasts (CAFs) via miR-105-5p. This exosomal microRNA may be a therapeutic target to disrupt tumor microenvironment coevolution.

Area Of Science

  • Oncology
  • Cell Biology
  • Molecular Medicine

Background

  • The tumor microenvironment (TME) is crucial for cancer progression.
  • Interactions between tumor cells and cancer-associated fibroblasts (CAFs) are key TME components.
  • Targeting cell-cell communication within the TME offers oncotherapy potential.

Purpose Of The Study

  • To investigate the role of breast cancer cell-derived exosomes in transforming normal fibroblasts (NFs) into CAFs.
  • To identify specific molecules within exosomes responsible for this transformation.
  • To explore the therapeutic potential of targeting this exosome-mediated process.

Main Methods

  • Exosome isolation from breast cancer cell lines with varying metastatic potential.
  • Co-culture experiments of NFs with breast cancer cell exosomes.
  • Quantitative analysis of exosomal microRNA content (miR-105-5p).
  • Luciferase reporter assays and Western blotting to assess gene expression (LATS2) and signaling pathways (NF-κB).

Main Results

  • Breast cancer cell exosomes induce NF to CAF transformation, with higher metastatic cells releasing more potent exosomes.
  • Exosomes from highly metastatic cells are enriched in miR-105-5p, which drives NF to CAF conversion.
  • Exosomal miR-105-5p downregulates LATS2 and activates NF-κB signaling, promoting CAF activation and cancer cell epithelial-mesenchymal transition (EMT).

Conclusions

  • Exosomal miR-105-5p facilitates breast cancer progression by transforming NFs into CAFs.
  • This exosome-mediated pathway represents a novel mechanism of tumor microenvironment modulation.
  • Targeting exosomal miR-105-5p offers a potential therapeutic strategy against breast cancer and CAF coevolution.

Related Concept Videos